JAMA Network June 3, 2024
Derek C. Angus, Alison J. Huang, Roger J. Lewis, Amy P. Abernethy, Robert M. Califf, Martin Landray, Nancy Kass, Kirsten Bibbins-Domingo for the JAMA Summit on Clinical Trials Participants

Importance
Optimal health care delivery, both now and in the future, requires a continuous loop of knowledge generation, dissemination, and uptake on how best to provide care, not just determining what interventions work but also how best to ensure they are provided to those who need them. The randomized clinical trial (RCT) is the most rigorous instrument to determine what works in health care. However, major issues with both the clinical trials enterprise and the lack of integration of clinical trials with health care delivery compromise medicine’s ability to best serve society.

Observations
In most resource-rich countries, the clinical trials and health care delivery enterprises function as separate entities, with siloed goals, infrastructure, and incentives. Consequently, RCTs are often poorly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Physician, Provider, Trends
FDA approves clinical trials for pig organ transplants
Supply chains and AI take precedence at European clinical trial meeting
Clinical trial: New drug combination reduces anemia in rare blood disorder
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges

Share This Article